Brief Reports
Copyright ©The Author(s) 2000.
World J Gastroenterol. Aug 15, 2000; 6(4): 593-596
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.593
Table 1 Tissue distribution of 131I-labeled L-HSA-liposomes in rat
Rat No.Tissue distribution in vivo (cpm per gram tissue)
LiverSpleenaKidneybHeartcLungd
131777.215394.27912.14427.59568.5
230476.115464.15424.53180.86044.1
330013.114041.47932.33777.55886.1
436099.310817.56372.33722.78717.3
536479.817882.67228.63885.57695.8
Average32969.114719.96974.13798.87582.4
Table 2 Tissue distribution of 131I labeled L-HSA-liposomes in rat, after L-HSA pre-injection
Rat No.Tissue distribution in vivo (cpm per gram tissue)
LiverSpleenaKidneybHeartcLungd
134682.035187.65535.72474.26368.0
220587.419791.14541.82277.28507.7
324288.827297.14564.42089.57280.7
433733.117637.55560.32698.312561.1
525600.918994.56999.23227.011087.1
Average27778.423781.67699.12553.28679.4
Table 3 Inhibitory effect on HBeAg expression in 2.2.15 cells of di fferent types of interferons
TreatmentInhibitory effect on HBeAg expression (%)
3 days6 days9 days12 days
Liposomes01.800
L-HSA-Liposomes0000
IFN 0.08 MUa04.712.72.3
CL-IFN 0.08 MUb0022.85.8
LL-IFN 0.08 MU44.860.743.545.5
LL-IFN 0.04 MU6.847.428.612.1
LL-IFN 0.02 MU024.623.84.6
LL-IFN 0.01 MU04.815.45.2